scholarly article | Q13442814 |
P356 | DOI | 10.1111/IJLH.12257 |
P698 | PubMed publication ID | 24845343 |
P50 | author | Yeung-Chul Mun | Q45532628 |
P2093 | author name string | W S Chung | |
J Huh | |||
H J Huh | |||
C M Seong | |||
C Hahm | |||
P2860 | cites work | Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms | Q24595117 |
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study | Q34037065 | ||
Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications | Q36769185 | ||
Conventional cytogenetics in myelofibrosis: literature review and discussion | Q37367516 | ||
Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies | Q37534893 | ||
Pathogenesis and consequences of uniparental disomy in cancer | Q37868831 | ||
High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations | Q40108060 | ||
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis. | Q40181513 | ||
Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates | Q46849228 | ||
Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm. | Q50574544 | ||
Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation. | Q50721189 | ||
Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. | Q51761197 | ||
Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance. | Q51805169 | ||
Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information. | Q51978963 | ||
Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm. | Q53281116 | ||
Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms. | Q53287852 | ||
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. | Q53312448 | ||
P433 | issue | 2 | |
P304 | page(s) | 181-189 | |
P577 | publication date | 2014-05-21 | |
P1433 | published in | International Journal of Laboratory Hematology | Q15751320 |
P1476 | title | Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. | |
P478 | volume | 37 |
Q34749608 | Clinical relevance of high-resolution single nucleotide polymorphism array in patients with relapsed acute lymphoblastic leukemia with normal karyotype: a report of three cases |
Q38860767 | Genomic profiling and directed ex vivo drug analysis of an unclassifiable myelodysplastic/myeloproliferative neoplasm progressing into acute myeloid leukemia |
Search more.